ArticleScientific reports2025

Mechanisms of rifaximin inhibition of hepatic fibrosis in mice with metabolic dysfunction associated steatohepatitis through the TLR4/NFκB pathway.

Ting Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.